{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:07:44Z","timestamp":1793423264221,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003182","name":"Siberian Branch, Russian Academy of Sciences","doi-asserted-by":"publisher","award":["125012300660-2"],"award-info":[{"award-number":["125012300660-2"]}],"id":[{"id":"10.13039\/501100003182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-30011"],"award-info":[{"award-number":["19-74-30011"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["23-73-10168"],"award-info":[{"award-number":["23-73-10168"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejpb.2026.114981","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:50:45Z","timestamp":1767455445000},"page":"114981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tuning the in vivo transfection efficiency of mRNA-Loaded lipoplexes by PEG-Lipid structure and ratio"],"prefix":"10.1016","volume":"220","author":[{"given":"O.V.","family":"Markov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Antropov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Shmendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Puchkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Yakovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Kerbitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Zhuravlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Dome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.P.","family":"Goncharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Shcherbakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Zenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Maslov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Stepanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.114981_b0005","first-page":"1","article-title":"SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2026.114981_b0010","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2026.114981_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2020.589959","article-title":"Advances in lipid nanoparticles for mRNA-based cancer immunotherapy","volume":"8","author":"Guevara","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2026.114981_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s40580-023-00385-3","article-title":"Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy","volume":"10","author":"Han","year":"2023","journal-title":"Nano Converg."},{"key":"10.1016\/j.ejpb.2026.114981_b0025","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejpb.2026.114981_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.114981_b0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2021.10.023","article-title":"Rational preparation and application of a mRNA delivery system with cytidinyl\/cationic lipid","volume":"340","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2026.114981_b0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.114981_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ejpb.2026.114981_b0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/C8MD00515J","article-title":"Diversity of PEGylation methods of liposomes and their influence on RNA delivery","volume":"10","author":"Nosova","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejpb.2026.114981_b0060","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3390\/molecules23123101","article-title":"Novel PEGylated liposomes enhance immunostimulating activity of isRNA","volume":"23","author":"Kabilova","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.114981_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15092184","article-title":"Influence of the composition of cationic liposomes on the performance of cargo immunostimulatory RNA","volume":"15","author":"Bishani","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.114981_b0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1134\/S1068162019010084","article-title":"Optimization of the technology for the preparation of cationic liposomes for the delivery of nucleic acids","volume":"44","author":"Luneva","year":"2018","journal-title":"Russ. J. Bioorganic Chem."},{"key":"10.1016\/j.ejpb.2026.114981_b0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11172-010-0071-x","article-title":"Synthesis of polycationic lipids based on cholesterol and spermine","volume":"59","author":"Petukhov","year":"2010","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejpb.2026.114981_b0080","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1016\/j.bmcl.2017.06.026","article-title":"Spacer structure and hydrophobicity influences transfection activity of novel polycationic gemini amphiphiles, Bioorganic Med","volume":"27","author":"Puchkov","year":"2017","journal-title":"Chem. Lett."},{"key":"10.1016\/j.ejpb.2026.114981_b0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41587-019-0164-5","article-title":"Human 5\u2032 UTR design and variant effect prediction from a massively parallel translation assay","volume":"37","author":"Sample","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.114981_b0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ymthe.2018.12.011","article-title":"Improving mRNA-based therapeuticgene delivery by expression-augmenting 3\u2032 UTRs identified by cellular library screening","volume":"27","author":"Orlandini von Niessen","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2026.114981_b0095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.18699\/vjgb-25-81","article-title":"A new combination of 5\u2019- and 3\u2019- untranslated regions increases the expression of mRNAs in vitro and in vivo., Vavilovskii Zhurnal Genet. i Sel","volume":"29","author":"Antropov","year":"2025","journal-title":"= Vavilov J Genet Breed"},{"key":"10.1016\/j.ejpb.2026.114981_b0100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/pharmaceutics16050684","article-title":"Novel efficient lipid-based delivery systems enable a delayed uptake and sustained expression of mRNA in human cells and mouse tissues","volume":"16","author":"Fedorovskiy","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.114981_b0105","doi-asserted-by":"crossref","unstructured":"V. Vysochinskaya, S. Shishlyannikov, Y. Zabrodskaya, E. Shmendel, S. Klotchenko, O. Dobrovolskaya, N. Gavrilova, D. Makarova, M. Plotnikova, E. Elpaeva, A. Gorshkov, D. Moshkoff, M. Maslov, A. Vasin, Influence of lipid composition of cationic liposomes 2X3-DOPE on mRNA delivery into eukaryotic cells, Pharmaceutics 15 (2023) 8. https:\/\/doi.org\/https:\/\/doi.org\/10.3390\/ pharmaceutics15010008.","DOI":"10.3390\/pharmaceutics15010008"},{"key":"10.1016\/j.ejpb.2026.114981_b0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejpb.2026.114981_b0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics5040542","article-title":"Surface engineering of liposomes for stealth behavior","volume":"5","author":"Nag","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.114981_b0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jconrel.2024.07.011","article-title":"Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease","volume":"373","author":"Lyu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2020.02.011","article-title":"Remodeling tumor immune microenvironment via targeted blockade of PI3K-\u03b3 and CSF-1\/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy","volume":"321","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0140","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/jpm14111092","article-title":"Advances in mRNA LNP-based cancer vaccines: Mechanisms, formulation aspects, challenges, and future directions","volume":"14","author":"Ramadan","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ejpb.2026.114981_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-024-02850-6","article-title":"Lipoplexes\u2019 structure, preparation, and role in managing different diseases","volume":"25","author":"El-Zahaby","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.114981_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117930","article-title":"Influence of the media ionic strength on the formation and in vitro biological performance of polycation-DNA complexes","volume":"344","author":"Coelho","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2026.114981_b0155","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/IJN.S363990","article-title":"Optimization of lipid nanoformulations for effective mRNA delivery","volume":"17","author":"Chen","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.114981_b0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2011.11.034","article-title":"Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets","volume":"160","author":"Markov","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2015.06.028","article-title":"Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model","volume":"213","author":"Markov","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114981_b0170","doi-asserted-by":"crossref","unstructured":"M. a. Maslov, T.O. Kabilova, I. a. Petukhov, N.G. Morozova, G. a. Serebrennikova, V. V. Vlassov, M. a. Zenkova, Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA, J. Control. Release 160 (2012) 182\u2013193. https:\/\/doi.org\/10.1016\/j.jconrel.2011.11.023.","DOI":"10.1016\/j.jconrel.2011.11.023"},{"key":"10.1016\/j.ejpb.2026.114981_b0175","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles \u2500 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.114981_b0180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307799120","article-title":"Dynamic carriers for therapeutic RNA delivery","volume":"121","author":"Berger","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2026.114981_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102325","article-title":"The dynamic process of mRNA delivery by lipid nanoparticles in vivo","volume":"57","author":"Ma","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.ejpb.2026.114981_b0190","doi-asserted-by":"crossref","unstructured":"R. Yang, Y. Deng, B. Huang, L. Huang, A. Lin, Y. Li, W. Wang, J. Liu, S. Lu, Z. Zhan, Y. Wang, R. A, W. Wang, P. Niu, L. Zhao, S. Li, X. Ma, L. Zhang, Y. Zhang, W. Yao, X. Liang, J. Zhao, Z. Liu, X. Peng, H. Li, W. Tan, A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity, Signal Transduct. Target. Ther. 6 (2021) 213. https:\/\/doi.org\/10.1038\/s41392-021-00634-z.","DOI":"10.1038\/s41392-021-00634-z"},{"key":"10.1016\/j.ejpb.2026.114981_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10101698","article-title":"Immunization with a prefusion SARS-CoV-2 spike protein vaccine (RBMRNA-176) protects against viral challenge in mice and nonhuman primates","volume":"10","author":"Ma","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ejpb.2026.114981_b0200","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2026.114981_b0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/08982104.2022.2071296","article-title":"Protein-liposome interactions: the impact of surface charge and fluidisation effect on protein binding","volume":"33","author":"Triantafyllopoulou","year":"2023","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2026.114981_b0210","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1039\/D2BM01846B","article-title":"Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury","volume":"11","author":"Waggoner","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2026.114981_b0215","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1007\/s00289-019-02924-7","article-title":"Nanoparticle opsonization: forces involved and protection by long chain polymers","volume":"77","author":"Wani","year":"2020","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ejpb.2026.114981_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123695","article-title":"Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines","volume":"650","author":"Yang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.114981_b0225","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.114981_b0230","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: Theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.114981_b0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2020.04.011","article-title":"Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon","author":"El Sayed","year":"2020","journal-title":"J. Control. Release 323"},{"key":"10.1016\/j.ejpb.2026.114981_b0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.114981_b0245","article-title":"Regulating immune responses induced by PEGylated messenger RNA\u2013lipid nanoparticle vaccine","volume":"13","author":"Jo","year":"2025","journal-title":"Vaccines"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:13:50Z","timestamp":1773994430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"alternative-id":["S0939641126000020"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.114981","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuning the in vivo transfection efficiency of mRNA-Loaded lipoplexes by PEG-Lipid structure and ratio","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.114981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114981"}}